The ubiquitin-proteasome pathway

被引:118
作者
Roos-Mattjus, P
Sistonen, L
机构
[1] Abo Akad Univ, Turku Ctr Biotechnol, Dept Biol, FIN-20520 Turku, Finland
[2] Univ Turku, SF-20500 Turku, Finland
关键词
cancer; HIF-1; alpha; p53; proteasome; SUMO; ubiquitin;
D O I
10.1080/07853890310016324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulating protein stability and turnover is a key task in the cell. Besides lysosomes, ubiquitin-mediated proteasomal degradation comprises the major proteolytic pathway in eukaryotes. Proteins destined for degradation by the proteasome are conjugated by a 'tag', a ubiquitin chain to a lysine, through an extensively regulated enzymatic cascade. The ubiquitylated proteins are subsequently targeted for degradation by the 26S proteasome, the major proteolytic machinery for ubiquitylated proteins in the cell. Ubiquitylation can be considered as another covalent posttranslational modification and signal, comparable to acetylation. glycosylation, methylation, and phosphorylation. However, ubiquitylation has multiple roles in addition to targeting proteins for degradation. Depending on the number of ubiquitin moieties and the linkages made, ubiquitin also plays an important role in DNA repair, protein sorting and virus budding. Unregulated degradation of proteins, or abnormally stable proteins, interfere with several regulatory pathways, and the ubiquitin-proteasome pathway is affected in a number of diseases, such as neurodegenerative diseases, cellular atrophies and malignancies. Therefore, dissecting the ubiquitin-proteasome pathway and identifying proteins involved in conjunction with the signals required for specific degradation of certain substrates, would help in developing novel therapeutic approaches to treat diseases where the ubiquitin-proteasome pathway is impaired.
引用
收藏
页码:285 / 295
页数:11
相关论文
共 64 条
[1]   Ubiquitin: not just for proteasomes anymore [J].
Aguilar, RC ;
Wendland, B .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :184-190
[2]   Stress signals utilize multiple pathways to stabilize p53 [J].
Ashcroft, M ;
Taya, Y ;
Vousden, KH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) :3224-3233
[3]   The proteasome:: Paradigm of a self-compartmentalizing protease [J].
Baumeister, W ;
Walz, J ;
Zühl, F ;
Seemuller, E .
CELL, 1998, 92 (03) :367-380
[4]   Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity [J].
Bies, J ;
Markus, J ;
Wolff, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) :8999-9009
[5]   Association of UNP, a ubiquitin-specific protease, with the pocket proteins pRb, p107 and p130 [J].
Blanchette, P ;
Gilchrist, CA ;
Baker, RT ;
Gray, DA .
ONCOGENE, 2001, 20 (39) :5533-5537
[6]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[7]   Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy [J].
Chène, P .
NATURE REVIEWS CANCER, 2003, 3 (02) :102-109
[8]   Angelman syndrome: a review of the clinical and genetic aspects [J].
Clayton-Smith, J ;
Laan, L .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (02) :87-95
[9]   The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein [J].
DeSalle, LM ;
Latres, E ;
Lin, D ;
Graner, E ;
Montagnoli, A ;
Baker, RT ;
Pagano, M ;
Loda, M .
ONCOGENE, 2001, 20 (39) :5538-5542
[10]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239